[go: up one dir, main page]

US20020025267A1 - Micro-Injection Pump - Google Patents

Micro-Injection Pump Download PDF

Info

Publication number
US20020025267A1
US20020025267A1 US09/885,667 US88566701A US2002025267A1 US 20020025267 A1 US20020025267 A1 US 20020025267A1 US 88566701 A US88566701 A US 88566701A US 2002025267 A1 US2002025267 A1 US 2002025267A1
Authority
US
United States
Prior art keywords
micro
syringe
fluid
linear
injection pump
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US09/885,667
Other languages
English (en)
Inventor
Baruch Lieber
Ajay Wakhloo
Stephen Rudin
Joseph Wodenscheck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Foundation of the State University of New York
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US09/885,667 priority Critical patent/US20020025267A1/en
Assigned to RESEARCH FOUNDATION OF SUNY AT BUFFALO, THE reassignment RESEARCH FOUNDATION OF SUNY AT BUFFALO, THE ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LIEBER, BARUCH B., RUDIN, STEPHEN, WAKHLOO, AJAY K., WODENSCHECK, JOSEPH A.
Publication of US20020025267A1 publication Critical patent/US20020025267A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/142—Pressure infusion, e.g. using pumps
    • A61M5/145—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons
    • A61M5/1452—Pressure infusion, e.g. using pumps using pressurised reservoirs, e.g. pressurised by means of pistons pressurised by means of pistons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
    • A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
    • A61M5/16804—Flow controllers
    • A61M5/16827—Flow controllers controlling delivery of multiple fluids, e.g. sequencing, mixing or via separate flow-paths
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/007—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests for contrast media

Definitions

  • the present invention relates generally to the field of controlled injection devices used to inject contrast media for angiography and therapeutic fluids for micro-intervention, and more particularly to a high-pressure micro-injection pump capable of injecting precise micro-liter fluid volumes into the vasculature and accurately controlling the velocity, acceleration, and timing of the injected fluid volumes.
  • the present invention finds particular application in the field of high-speed pulsed digital subtraction angiography (DSA).
  • DSA digital subtraction angiography
  • U.S. Pat. No. 3,623,474 describes an angiographic injector system having automatic syringe drive means controlled by a programmable command signal, such that an operator may select an injection flow rate. The actual flow rate is monitored and a feedback signal is generated to maintain the desired flow rate regardless of flow attenuating factors such as catheter internal diameter, catheter length, contrast medium viscosity, and flow path configuration.
  • the described system includes a rate trip circuit for preventing delivery of excessive flow to the patient should the control system fail.
  • An improved angiographic control system by the same inventors is disclosed in U.S. Pat. No.
  • a micro-injection pump formed in accordance with a preferred embodiment of the present invention generally comprises first and second linear traverses each having a syringe holder for holding respective first and second micro-syringes, and a carriage-mounted pusher element for engaging a plunger of the associated micro-syringe.
  • the first micro-syringe preferably contains a volume of a soluble contrast medium
  • the second micro-syringe preferably contains a volume of an insoluble contrast medium.
  • Each linear traverse includes a stepper motor for allowing very accurate control of the position, velocity, and acceleration of the traverse carriage.
  • Fluid discharged by the micro-syringes is directed to a bifurcated micro-droplet generator having a straight primary passage and an obliquely merging tributary passage. More specifically, insoluble contrast medium from the second micro-syringe flows through a micro-sized injection needle extending partially and coaxially within the primary passage to a termination point just downstream from where the tributary passage joins the primary passage. Soluble contrast medium from the first micro-syringe is routed through the tributary passage to provide a flow field surrounding the injection needle, thereby providing shear force to separate discrete same-sized boluses from the terminal tip of the injection needle at regular time intervals in coordination with a predetermined motion profile of the first and second linear traverses.
  • Motion control of the linear traverses is possible using LABVIEW® virtual instrumentation software arranged to communicate with a 2-axis indexer control connected to first and second motor indexers for driving the stepper motors.
  • Linear potentiometers mounted on the traverses, rotary encoders connected to the stepper motors, a flowmeter, and pressure transducers indicate motion and flow parameters of the system in real-time to provide a feedback loop in the system so that a desired media delivery waveform is realized.
  • FIG. 1 is a perspective view of a micro-injection pump formed in accordance with a preferred embodiment of the present invention
  • FIG. 2 is a top plan view of the micro-injection pump shown in FIG. 1, with syringe plungers in a ready position;
  • FIG. 3 is a partial top plan view similar to that of FIG. 2, with syringe plungers in a discharged position;
  • FIG. 4 is a partially sectioned detail view taken generally along the line 4 - 4 in FIG. 1 showing a micro-droplet generator of the present invention
  • FIG. 5 is a schematic view illustrating initial formation of a liquid bolus of insoluble contrast medium by the micro-droplet generator shown in FIG. 4;
  • FIG. 6 is a schematic view similar to that of FIG. 5 illustrating separation and conveyance of a liquid bolus of insoluble contrast medium
  • FIG. 7 is a schematic system diagram showing currently preferred hardware connections of the present invention.
  • FIG. 8 is a screen capture of a LABVIEW® front panel showing a Contrast Injector virtual instrument (VI) for operating the micro-injection pump of the present invention
  • FIG. 9 shows a first of three main LABVIEW® graphical object-based software sequence frames associated with the Contrast Injector VI, wherein the first frame comprises an initializing and homing configuration routine for the Contrast Injector VI;
  • FIG. 10A shows a second of three main LABVIEW® software sequence frames associated with the Contrast Injector VI, wherein the second frame comprises a main sequence structure associated with the Contrast Injector VI depicted with blank schematic representations of independent sequences ( 2 ) through ( 6 ) illustrated fully in subsequent figures;
  • FIG. 10B fully shows LABVIEW® software sequences ( 2 ) and ( 3 ) represented schematically in FIG. 10A;
  • FIG. 10C fully shows LABVIEW® software sequence ( 4 ) represented schematically in FIG. 10A;
  • FIG. 10D fully shows LABVIEW® software sequences ( 5 ) and ( 6 ) represented schematically in FIG. 10A;
  • FIG. 11 shows a third of three main LABVIEW® software sequence frames associated with the Contrast Injector VI, wherein the third frame comprises a shut down routine for the Contrast Injector VI;
  • FIG. 12 is a screen capture of a LABVIEW® front panel showing a Profile Tracker virtual instrument (VI) for operating the micro-injection pump of the present invention according to a predefined injection flow profile chosen by the user;
  • VIP Profile Tracker virtual instrument
  • FIG. 13 shows a first of three main LABVIEW® software sequence frames associated with the Profile Tracker VI, wherein the first frame comprises an initializing and homing configuration routine for the Profile Tracker VI;
  • FIG. 14A shows a second of three main LABVIEW® software sequence frames associated with the Profile Tracker VI, including a Trace Option alternative case control structure shown in its true condition, a second of three sequence sub-frames nested in the Trace Option alternative case control structure, and an inner alternative case control structure nested in the second sequence sub-frame shown in its true condition;
  • FIG. 14B shows the Trace Option alternative case control structure shown in FIG. 14A, however in its false condition
  • FIG. 14C shows a first of three sequence sub-frames nested in the Trace Option alternative case control structure shown in FIG. 14A;
  • FIG. 14D shows a third of three sequence sub-frames nested in the Trace Option alternative case control structure shown in FIG. 14A;
  • FIG. 14E shows the inner alternative case control structure nested in the second sub-frame sequence shown in FIG. 14A, however in its false condition;
  • FIG. 15 shows a third of three main LABVIEW® software sequence frames associated with the Profile Tracker VI, wherein the third frame comprises a shut down routine for the Profile Tracker VI.
  • a micro-injection pump 10 of the present invention is shown as comprising a first linear traverse 12 operable along a first axis 12 A, and a second linear traverse 14 operable along a second axis 14 A.
  • First linear traverse 12 includes a track 12 B and a carriage 12 C mounted on track 12 B for back and forth driven motion along first axis 12 A.
  • a stepper motor 12 D is located at a front end of first linear traverse 12 and connected to carriage 12 C via a drive coupler 12 E and drive shaft (not shown).
  • Carriage 12 C supports an upstanding pusher element 12 F which is axially movable with the carriage relative to a stationary syringe holder 12 G provided near the front of first linear traverse 12 .
  • Travel limit switches 12 H are also provided.
  • second linear traverse 14 includes a track 14 B, carriage 14 C, stepper motor 14 D, drive coupler 14 E, pusher element 14 F, syringe holder 14 G, and limit switches 14 H in similar arrangement.
  • syringe holder 12 G on first linear traverse 12 holds a first micro-syringe 16 preferably filled with an amount of a soluble contrast medium 18 .
  • First micro-syringe 16 includes an axially movable plunger 16 A having a distal end 16 B engaged by pusher element 12 F.
  • Syringe holder 14 G on second linear traverse 14 holds a second micro-syringe 20 which, for evaluation and intervention applications, may be filled with an amount of an insoluble contrast medium 22 such as ETHIODOL® available from Savage Laboratories of Melville, N.Y.
  • Second micro-syringe 20 includes an axially movable plunger 20 A having a distal end 20 B engaged by pusher element 14 F.
  • First and second micro-syringes 16 and 20 are in flow communication with a micro-droplet generator 28 by way of catheter tubes 24 and 26 respectively coupled to the outlet ports of micro-syringes 16 and 20 .
  • Micro-droplet generator 28 feeds a micro-catheter 29 in flow communication with the vasculature of a patient.
  • Micro-droplet generator 28 is shown in detail in FIGS. 4 - 6 .
  • Micro-droplet generator 28 includes a bifurcated junction member 30 upstream from a reducer 32 threadably joined thereto.
  • Junction member 30 includes a tributary port 30 A fed by first micro-syringe 16 via catheter tube 24 and closable valve 25 , an inlet port 30 B fed by second micro-syringe 20 via catheter tube 26 , and an outlet port 30 C opposite inlet port 30 B.
  • Inlet port 30 B is connected for flow communication with outlet port 30 C by a straight primary passageway 30 D
  • tributary port 30 A is connected for flow communication with primary passageway 30 D by a tributary passageway 30 E forming an acute angle with primary passageway 30 D.
  • a narrow injection needle 34 extends partially within primary passageway 30 D from inlet port 30 B to a region just downstream from the junction of tributary passageway 30 E with primary passageway 30 D. Clearance is provided between the outer wall of injection needle 34 and the inner wall defining primary passageway 30 D to allow fluid to occupy the intervening space.
  • primary passageway 30 D has an inner diameter of 2.00 mm.
  • An adjustable sealing coupler 36 normally provides a fluid tight seal about injection needle 34 , and can be loosened to bleed the system such that fluid that is free of air bubbles occupies the intervening space.
  • micro-liter precision for injection volumes and accurate control of dosage velocity and acceleration are achieved by computerized motion control of first and second linear traverses 12 and 14 actuating micro-syringes 16 and 20 , respectively.
  • Linear traverses 12 and 14 can be controlled according to any predetermined profile to achieve necessary delivery parameters.
  • the schematic system diagram of FIG. 7 illustrates the currently preferred hardware arrangement for micro-injection pump 10 .
  • Stepper motor 12 D is connected to a first motor indexer drive 46 by lead 48
  • stepper motor 14 D is connected to a second motor indexer drive 50 by lead 52 .
  • First and second indexer drives 46 and 50 are, for example, Parker Compumotor Zeta 4 drives having respective motor drive ports 54 and 56 to which leads 48 and 52 are connected.
  • a 2 -axis indexer control 58 is linked for serial communications with a central processing unit 60 via an RS232 cable 62 .
  • indexer control 58 is a Parker Compumotor 6200 controller with dual axis capability
  • RS232 cable 62 is linked to an auxiliary port 64 of indexer control 58 .
  • the indexer control board includes a Drive 1 port 66 connected by cable 68 to an indexer port 70 on first motor indexer drive 46 , and a Drive 2 port 72 connected by cable 74 to an indexer port 76 on second motor indexer drive 50 .
  • Indexer control 58 further includes a limit switch port 78 to which limit switches 12 H and 14 H can be connected by leads 80 and 82 .
  • Hardware is preferably installed for providing feedback information to computer 60 describing system variables.
  • a pair of linear potentiometers 84 and 86 are matched with first and second linear traverses 12 and 14 , respectively, for tracking position, velocity, and acceleration information with regard to each traverse in real time.
  • a suitable linear potentiometer for the example system described herein is a Type HLP190/SA1/150/6K available from Penny & Giles Controls Limited.
  • two rotary encoders 85 and 87 are also employed for position, velocity, and acceleration feedback with respect to first and second linear traverses 12 and 14 .
  • Encoders 85 and 87 are attached to corresponding drive motors 12 D and 14 D via a flexible shaft connection.
  • a suitable encoder for the example system described herein is a model C150/152/153 distributed by Dynamic Research Corp, having a resolution of 8000 counts per revolution.
  • a pair of pressure transducers 88 and 90 available for example from Validyne of Northridge, Calif., monitor fluid pressure as fluid exits first and second micro-syringes 16 and 20 , respectively.
  • a flowmeter 92 is preferably installed to measure flow rates for each micro-syringe.
  • the model T206 flowmeter available from Transonic Systems Inc. of Ithaca, N.Y. can perform this function.
  • FIG. 8 is a screen capture of a Contrast VI front panel 100 showing a virtual control screen for operating micro-injection pump 10 .
  • Contrast Injection front panel 100 includes a home button 102 for running a home positioning routine, a start button 104 , a stop button 106 , and an escape button 108 .
  • a quit button 110 is also provided for exiting from front panel 100 .
  • a two-axis graphical display 112 reports theoretical and measured flow rates in real time for first and second micro-syringes 16 and 20 , with corresponding digital readouts 114 and 116 preferably being provided as well.
  • Stepper motors 12 D and 14 D can be assigned “soft” travel limits in the clockwise and counter-clockwise directions using digital controls 118 A, 118 B and 118 C, 118 D, or using their corresponding pointers 119 A, 119 B and 119 C, 119 D on bar graphs 121 and 123 , respectively.
  • Bar graphs 121 and 123 provide a visual indication of the individual syringe volumes injected by first micro-syringe 16 and second micro-syringe 20 , measured in cubic centimeters, with the scale of each bar graph being dependent upon the chosen syringe size.
  • Corresponding digital displays 122 and 124 also report the injected volumes for the respective syringes in digital format.
  • two pairs of LED indicators 120 A, 120 B and 120 C, 120 D illuminate when the traverse has crossed the associated soft limit setting.
  • Controls for first linear traverse 12 include a syringe size selector 126 and a velocity knob control 128 .
  • a digital flow rate control terminal 130 shows the flow rate in cc/sec based on the selected syringe size and velocity, and can be used to directly choose a desired flow rate and thus set a corresponding velocity.
  • controls associated with second linear traverse 14 include a syringe size selector 132 , a velocity knob control 134 , and a digital flow rate control terminal 136 .
  • a predetermined time delay for starting motion of second linear traverse 14 is selectable at delay control portion 138 of front panel 100 .
  • a hardware trigger button 139 (Digital Trigger Enable) is also provided to enable synchronized injections with ECG and angiographic equipment.
  • a profile tracker button 140 (Profile Tracker Enable) which is used to call the Profile Tracker VI software.
  • Profile Tracker front panel described below, stays in the foreground until the user exits from the Profile Tracker front panel, at which time the Contrast Injector front panel 100 will come to the foreground and re-engage.
  • a linear traverse direction toggle 141 and a soft limit enable toggle 142 allow further control of microinjection pump 10 .
  • FIGS. 9 , 10 A- 10 D, and 11 are directed to three main sequence frames of the Contrast Injector VI.
  • FIG. 9 shows a first frame 144 containing a motor controller initializing routine and a homing configuration routine.
  • Home configuration blocks 146 and 148 determine the velocity, acceleration, and deceleration of the homing routines for first linear traverse 12 and second linear traverse 14 , respectively.
  • there is a parameter precision “sub-VI” 145 which is preferably used to specify a three decimal place level of precision on all numbers sent to the motor controller 58 , thereby improving communications performance.
  • Motion scaling sub-VIs 147 and 149 are issued to scale position, velocity, and acceleration parameters for the specified motors.
  • FIGS. 10 A- 10 D show a second frame 150 containing a main sequence structure of the Contrast Injector VI software.
  • a main “while loop” 152 contains six independent sequence frames ( 1 )-( 6 ), an alternative case structure ( 7 ), and sub-VIs 151 for stopping the program and halting motor motion.
  • Sequence ( 1 ) takes in velocity information from the velocity knob controls 128 and 134 , scales the data and sends the information to the motor controller.
  • Sequence ( 1 ) also provides a direction sub-VI 153 for setting the travel direction of both linear traverses.
  • Sequence ( 2 ) best seen in FIG.
  • Sequence ( 3 ), also shown in Fig. 10B, is used to scale slider bars 121 and 123 , which indicate volumes injected for each syringe pump, and also to scale the appropriate soft limit controls.
  • Sequence ( 4 ) shown in Fig. 10C enables and disables both the delay timer and the hardware trigger.
  • the outer most case structure 154 enables or disables the hardware trigger by checking the hardware trigger button 139 on the front panel.
  • the system can be started by clicking on the start button 108 or by reading a transistor transistor logic (TTL) digital input high, acquired from controller 58 . This is especially useful when injections need to be synchronized with an angiographic run or with the cardiac cycle.
  • TTL transistor transistor logic
  • the inner case structure 156 enables or disables the second linear traverse delay timer. Referring now to FIG. 10D, sequence ( 5 ) is used to scale and set “soft” limits. Sequence ( 6 ) checks the software limits'status and sends pass/fail information to LED indicators 120 A- 120 D on Contrast Injector front panel 100 .
  • the final structure in while loop 152 (FIG. 10A) is an alternative case structure ( 7 ) used to call a secondary program, namely the Profile Tracker VI mentioned above.
  • FIG. 11 shows a third frame 160 of the Contrast Injector VI for shutting down the apparatus.
  • Inputs to an enable motor drive sub-VI 162 are changed to disable the motor drives, and a close device sub-VI 164 is executed for shutting down the virtual instrumentation.
  • FIG. 12 shows a front panel 200 of the Profile Tracker VI software mentioned above.
  • the Profile Tracker program is utilized during injection of embolic agents, and has the capability of injecting a single syringe of fluid at a variable rate.
  • the user predetermines the rates of injection by selecting a predefined injection flow profile from a Profile Menu presented by a drop down text box 201 .
  • the user can also run new and unique profiles with the system by selecting “user defined profile” in the aforementioned drop down menu.
  • the user needs only to create a profile data set in “.txt” format and in units of cc/sec, and load the data set into the program.
  • the Profile Tracker VI front panel 200 has motion control buttons including a home button 202 , a start button 204 , a stop button 206 , and a quit button 210 .
  • a syringe size/loading control panel 212 includes a drop down menu 214 from which a user can select one of a plurality of standard and user-programmable syringe sizes, and a load toggle 216 for moving carriage 14 C and pusher element 14 F into proper position for loading and unloading syringes.
  • the Profile Tracker VI includes a proportional plus integral plus derivative (P.I.D.) feedback control loop to ensure proper tracking of specified injection flow profiles.
  • the P.I.D. VI controls are placed in a “PID Parameter Settings & Gain Scheduling” panel 220 . These controls allow the user to tune the P.I.D. controller.
  • the graph 228 plots the predetermined profile data in solid white line and the Profile Trackers VI's real time actual flow profile data in colored circles. There are four basic steps to using the Profile Tracker VI: first, load a desired syringe; second, select the corresponding syringe size; third, choose a preferred injection flow profile from profile menu 201 ; and fourth, select “Start Profile Tracker” button 203 when ready.
  • FIG. 13 illustrates a first frame 230 of three main sequence frames of the Profile Tracker VI.
  • First frame 230 includes a motor controller initializing routine and homing configuration routine.
  • Home configuration sub-VIs 232 and 234 determine the velocity, acceleration and deceleration of the homing routines for first linear traverse 12 and second linear traverse 14 , respectively.
  • FIGS. 14 A- 14 E show a second frame 240 containing a main sequence structure of the Profile Tracker VI.
  • the while loop 242 contains a file selector sub-VI 244 which is used to retrieve a predetermined injection profile or allows the user to search for a specific file.
  • Data and trace graph attribute nodes 246 and 248 respectively ensure that the data graph and the real time trace graph have the same scaling.
  • a motor engage control sub-VI 254 has an alternate case structure 256 adjacent to it in order to enable resetting or unlatching of the start button 204 after it has been depressed.
  • the outer most alternate case structure 260 is a Trace Option case structure used to determine if the profile trace program should be initiated, as determined by the Start Profile Tracker button 203 located on the front panel 200 . If button 203 is “ON”, Trace Option case structure 260 executes according to the “true” condition as depicted in FIG. 14A. If button 203 is “OFF”, Trace Option case structure 260 executes according to the “false” condition as depicted in FIG. 14B.
  • inner alternate case structure 264 is likewise determined by Start Profile Tracker button 203 , with a “false” condition of case structure 264 being shown in FIG. 14E.
  • the nested sequence sub-frame 262 which is the second in a series of three sub-frames 261 - 263 , serves to dump the data from a selected injection profile file to the P.I.D. control loop and to designate a time base for the data to be read and moves to be executed.
  • FIG. 14C shows first sequence sub-frame 261 which functions to clear the feedback history data of the trace graph 228 .
  • FIG. 14D shows third sequence sub-frame 263 programmed to ask the user if he or she would like to run another profile by bringing up a pop up window with yes and no buttons. This function is disengaged when the user clicks quit button 210 . Third sub-frame 263 also unlatches both Start Profile Tracker button 203 and stop button 206 .
  • a third frame 270 of the three main sequence frames of the Profile Tracker VI is shown in FIG. 15, and is similar to the third frame 160 of Contrast Injector VI 160 .
  • Third frame 270 shuts down the apparatus by changing inputs to an enable motor drive sub-VI 272 to disable the motor drives and by executing a close device sub-VI 274 for closing down the virtual instrumentation.
  • the micro-injection pump of the present invention maintains accurate flow rates under high pressure loading.
  • a micro-injection pump as described above demonstrated the capability to deliver 1.0 ⁇ 0.1 microliters at high pressure up to 20 atmospheres.
  • Micro-injection pump 10 is compatible with a an assortment of syringes and micro-catheters commonly used in micro-intervention procedures. While not described above, it is of course advisable to provide safety features, such as automatic shut-off and alarm features, to prevent serious complications in the event of a system malfunction.
  • Benefits of the present invention include improved quantitative measurements of blood flow patterns, more precise transit time estimates, and greatly improved visualization of complex hemodynamics associated with arteriovenous malformations.

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
US09/885,667 2000-06-22 2001-06-20 Micro-Injection Pump Abandoned US20020025267A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US09/885,667 US20020025267A1 (en) 2000-06-22 2001-06-20 Micro-Injection Pump

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21331900P 2000-06-22 2000-06-22
US09/885,667 US20020025267A1 (en) 2000-06-22 2001-06-20 Micro-Injection Pump

Publications (1)

Publication Number Publication Date
US20020025267A1 true US20020025267A1 (en) 2002-02-28

Family

ID=22794628

Family Applications (1)

Application Number Title Priority Date Filing Date
US09/885,667 Abandoned US20020025267A1 (en) 2000-06-22 2001-06-20 Micro-Injection Pump

Country Status (3)

Country Link
US (1) US20020025267A1 (fr)
AU (1) AU2001271347A1 (fr)
WO (1) WO2001097901A2 (fr)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475188B1 (en) * 1999-05-20 2002-11-05 Anthony David Baxter Bilateral microinjector pump for freely moving animals in an operant chamber
US20050148867A1 (en) * 2003-12-31 2005-07-07 Liebel-Flarsheim Company Injector with changeable syringe constants
US20050177109A1 (en) * 2004-02-06 2005-08-11 Graziano Azzolini Infusion pump for syringes
US20060258985A1 (en) * 2005-05-11 2006-11-16 Russell Claudia J Graphical display of medication limits and delivery program
US20080038124A1 (en) * 2004-06-30 2008-02-14 Erbe Elektromedizin Gmbh Medical Pump
US20090060764A1 (en) * 2004-06-30 2009-03-05 Erbe Elektromedizin Gmbh Medical Pump
US20090093065A1 (en) * 2007-09-10 2009-04-09 Zhong Ding Aspirating and dispensing small volumes of liquids
US20120183455A1 (en) * 2009-04-06 2012-07-19 Bennett Richard K Laboratory syringe pumps
CN103042386A (zh) * 2012-12-31 2013-04-17 安徽工业大学 基于labview的回转支承安装系统及其控制方法
US20140252025A1 (en) * 2011-08-17 2014-09-11 Henkel Ag & Co Kgaa Discharging system
US9057363B2 (en) 2007-12-10 2015-06-16 Bayer Medical Care, Inc. Continuous fluid delivery system
US10332623B2 (en) * 2017-01-17 2019-06-25 Kaleo, Inc. Medicament delivery devices with wireless connectivity and event detection
US10507319B2 (en) 2015-01-09 2019-12-17 Bayer Healthcare Llc Multiple fluid delivery system with multi-use disposable set and features thereof
US11141123B2 (en) * 2014-12-02 2021-10-12 Koninklijke Philips N.V. Fractional flow reserve determination
US11929160B2 (en) 2018-07-16 2024-03-12 Kaleo, Inc. Medicament delivery devices with wireless connectivity and compliance detection

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10208776A1 (de) * 2002-02-28 2003-09-04 Muefa Ag Infusionseinheit
US7270648B2 (en) 2002-12-23 2007-09-18 Farhad Kazemzadeh Drug delivery apparatus
US9050400B2 (en) 2008-08-12 2015-06-09 Osprey Medical, Inc. Remote sensing catheter system and methods
US9295816B2 (en) 2009-12-09 2016-03-29 Osprey Medical, Inc. Catheter with distal and proximal ports
EP2741804B1 (fr) 2011-08-11 2017-04-26 Osprey Medical Inc. Système et procédé de traitement des membres
CN110674564B (zh) * 2019-04-09 2024-02-02 哈尔滨理工大学 基于Labview的主轴姿态计算方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3623474A (en) 1966-07-25 1971-11-30 Medrad Inc Angiographic injection equipment
US3701345A (en) 1970-09-29 1972-10-31 Medrad Inc Angiographic injector equipment
US3812843A (en) 1973-03-12 1974-05-28 Lear Siegler Inc Method and apparatus for injecting contrast media into the vascular system
US5256157A (en) * 1991-01-31 1993-10-26 Baxter International Inc. Automated infusion pump with replaceable memory cartridges
US5472403A (en) * 1993-05-11 1995-12-05 The Regents Of The University Of California Device for automatic injection of radionuclide
US5827219A (en) * 1993-10-28 1998-10-27 Medrad, Inc. Injection system and pumping system for use therein
US6221045B1 (en) * 1995-04-20 2001-04-24 Acist Medical Systems, Inc. Angiographic injector system with automatic high/low pressure switching
EP0824022A1 (fr) * 1996-08-12 1998-02-18 Microflow Engineering SA Système d'administration parentérale de médicaments

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6475188B1 (en) * 1999-05-20 2002-11-05 Anthony David Baxter Bilateral microinjector pump for freely moving animals in an operant chamber
JP2007516778A (ja) * 2003-12-31 2007-06-28 マリンクロッド・インコーポレイテッド 変更可能なシリンジ定数を有する注入器
US20050148867A1 (en) * 2003-12-31 2005-07-07 Liebel-Flarsheim Company Injector with changeable syringe constants
WO2005065746A1 (fr) 2003-12-31 2005-07-21 Mallinckrodt Inc. Injecteur a constantes de seringue modifiables
US20050177109A1 (en) * 2004-02-06 2005-08-11 Graziano Azzolini Infusion pump for syringes
US7347837B2 (en) * 2004-02-06 2008-03-25 Graziano Azzolini Infusion pump for syringes
US7955057B2 (en) * 2004-06-30 2011-06-07 Erbe Elektromedizin Gmbh Medical pump
US20080038124A1 (en) * 2004-06-30 2008-02-14 Erbe Elektromedizin Gmbh Medical Pump
US20090060764A1 (en) * 2004-06-30 2009-03-05 Erbe Elektromedizin Gmbh Medical Pump
EP1891564A1 (fr) * 2005-05-11 2008-02-27 Cardinal Health 303, Inc. Affichage graphique de limites et de plan d'administration de medicament
WO2006124202A1 (fr) 2005-05-11 2006-11-23 Cardinal Health 303, Inc. Affichage graphique de limites et de plan d'administration de medicament
US20060258985A1 (en) * 2005-05-11 2006-11-16 Russell Claudia J Graphical display of medication limits and delivery program
AU2006248008B2 (en) * 2005-05-11 2012-05-31 Carefusion 303, Inc. Graphical display of medication limits and delivery program
US20090093065A1 (en) * 2007-09-10 2009-04-09 Zhong Ding Aspirating and dispensing small volumes of liquids
US9057363B2 (en) 2007-12-10 2015-06-16 Bayer Medical Care, Inc. Continuous fluid delivery system
US20120183455A1 (en) * 2009-04-06 2012-07-19 Bennett Richard K Laboratory syringe pumps
US20140252025A1 (en) * 2011-08-17 2014-09-11 Henkel Ag & Co Kgaa Discharging system
US9359122B2 (en) * 2011-08-17 2016-06-07 Henkel Ag & Co. Kgaa Discharging system
CN103042386A (zh) * 2012-12-31 2013-04-17 安徽工业大学 基于labview的回转支承安装系统及其控制方法
US11141123B2 (en) * 2014-12-02 2021-10-12 Koninklijke Philips N.V. Fractional flow reserve determination
US11490867B2 (en) 2014-12-02 2022-11-08 Koninklijke Philips N.V. Fractional flow reserve determination
US10507319B2 (en) 2015-01-09 2019-12-17 Bayer Healthcare Llc Multiple fluid delivery system with multi-use disposable set and features thereof
US11491318B2 (en) 2015-01-09 2022-11-08 Bayer Healthcare Llc Multiple fluid delivery system with multi-use disposable set and features thereof
US12201802B2 (en) 2015-01-09 2025-01-21 Bayer Healthcare Llc Multiple fluid delivery system with multi-use disposable set and features thereof
US10332623B2 (en) * 2017-01-17 2019-06-25 Kaleo, Inc. Medicament delivery devices with wireless connectivity and event detection
US10937537B2 (en) 2017-01-17 2021-03-02 Kaleo, Inc. Medicament delivery devices with wireless connectivity and event detection
US11929160B2 (en) 2018-07-16 2024-03-12 Kaleo, Inc. Medicament delivery devices with wireless connectivity and compliance detection

Also Published As

Publication number Publication date
WO2001097901A3 (fr) 2002-05-30
AU2001271347A1 (en) 2002-01-02
WO2001097901A2 (fr) 2001-12-27

Similar Documents

Publication Publication Date Title
US20020025267A1 (en) Micro-Injection Pump
US4919596A (en) Fluid delivery control and monitoring apparatus for a medication infusion system
US5140862A (en) Injection pump calibration device
US5292306A (en) Method of detecting occlusions in a solution pumping system
US4589372A (en) Dispensing system having weight dependent control means
US5464392A (en) Infusion system having plural fluid input ports and at least one patient output port
EP0319267B1 (fr) Dispositif de commande et de surveillance de débit de fluide
US4952205A (en) Pressure infusion device
CA2551817C (fr) Detection de recipients vides utilisant le captage de pression du cote recipient
US4602249A (en) Method and apparatus for detecting leaking valves in a volumetric infusion device
EP1044072B1 (fr) Procede et appareil destines a la distribution rapide pour former un motif en pointille
US4255088A (en) Liquid pumping system having means for detecting gas in the pump
US4396385A (en) Flow metering apparatus for a fluid infusion system
KR900002807A (ko) 제2차 주입 모듈을 가진 이중 소스 비경구적 주입 시스템
JPH01265973A (ja) 閉鎖された多数流体放出システムおよび方法
EP0288717A1 (fr) Système d'infusion sensible à la pression
CN113713202A (zh) 高压造影剂注射系统
US4212298A (en) Thermodilution injector
US4601700A (en) Method for flow control monitoring
WO1981000519A1 (fr) Controleur d'ecoulement de fluide
JP3184831B2 (ja) 複数の輸液または薬液を連続同時投与する装置
JPS58126489A (ja) ポンプ
KR102839679B1 (ko) 수액정보 표시 장치
JPS5826224A (ja) 流体計量装置における計量異常検出方法
TW202406583A (zh) 輸注輸送裝置

Legal Events

Date Code Title Description
AS Assignment

Owner name: RESEARCH FOUNDATION OF SUNY AT BUFFALO, THE, NEW Y

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:LIEBER, BARUCH B.;WAKHLOO, AJAY K.;RUDIN, STEPHEN;AND OTHERS;REEL/FRAME:012179/0572

Effective date: 20010809

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION